Material Agreements

Skye Bioscience, Inc. amended Amendment with certain investors (effective 2024-03-11).

“Concurrently and in connection with the Private Placement, the Company entered into an amendment (the “Amendment”) to the warrants issued pursuant to that certain Securities Purchase Agreement, dated August 15, 2023, by and between the Company and certain investors (the “2023 PIPE Warrants”).”

Skye Bioscience, Inc. entered into Registration Rights Agreement with the Investors (effective 2024-03-11).

“On March 11 , 2024, concurrently and in connection with the execution of the Purchase Agreement, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investors, pursuant to which the Investors will have certain customary registration rights, and the Company will be required to prepare and file a resale registration statement (the “Registration Statement”) with the SEC to register the resale of the Shares and the Warrant Shares within 60 days after the date of the Registration Rights Agreement (the “Filing Date”), and to use reasonable best efforts to have the Registration Statement declared effective as promptly as possible thereafter, and in any event no later than 30 days following the Filing Date (or 60 days following the Filing Date in the event the SEC reviews and has written comments to the Registration Statement).”

Skye Bioscience, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $40,000,000 (effective 2024-03-11).

“On March 11 , 2024, Skye Bioscience, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Investors”) to issue and sell at closing an aggregate of 4,000,000 shares (the “Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”), at a price of $ 10.00 per Share (the "Private Placement").”

BlueOne Card, Inc. entered into Master Program Manager Services Agreement with a third-party bank (effective 2024-02-27).

“On March 5, 2024, the Board of Directors of BlueOne Card, Inc., a Nevada corporation (the “ Company ”), approved and ratified the Company entering into the Master Program Manager Services Agreement dated February 27, 2024 (the “ Agreement ”) with a third-party bank (the “ Bank ”).”

Scorpius Holdings, Inc. amended Amendment No. 7 with Continental Stock Transfer & Trust Company (effective 2024-03-11).

“On March 11, 2024, Scorpius Holdings, Inc. (formerly known as NightHawk Biosciences, Inc.) (the “Company”) entered into Amendment No. 7 (“Amendment No. 7”) dated March 11, 2024 to the Rights Agreement dated March 11, 2018 (the “Original Rights Agreement”), as amended by Amendment No. 1 thereto (“Amendment No. 1”) dated March 8, 2019, Amendment No. 2 thereto (“Amendment No. 2”) dated March 10, 2020, Amendment No. 3 thereto (“Amendment No. 3”) dated March 8, 2021, Amendment No. 4 thereto (“Amendment No. 4”) dated March 11, 2022, Amendment No. 5 thereto (“Amendment No. 5”) dated March 11, 2023, and Amendment No. 6 thereto (“Amendment No. 6”) dated December 11, 2023 (collectively, the “Rights Agreement”) by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.”

ESPORTS ENTERTAINMENT GROUP, INC. entered into Secured Note Purchase Agreement with the holder of Series C Convertible Preferred Stock and Series D Convertible Preferred Stock valued at approximately $1.42 million (effective 2024-03-07).

“On March 13, 2024, Esports Entertainment Group, Inc. (the “Company”) announced that it entered into an agreement, dated March 7, 2024 (the “Secured Note Purchase Agreement”) with the holder (the “Holder”) of its Series C Convertible Preferred Stock (“Series C Preferred Stock”) and Series D Convertible Preferred Stock (the “Series D Preferred Stock”), pursuant to which the Company issued the Holder a secured promissory note (the “Secured Note”), for approximately $1.42 million in cash and certain amendments to the terms of the Series C Preferred Stock and Series D Preferred Stock.”

COGNITION THERAPEUTICS INC entered into Underwriting Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2024-03-11).

“On March 11, 2024, Cognition Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Underwriter”), pursuant to which the Company agreed to issue and sell to the Underwriter, in a public offering (the “Offering”), 6,571,428 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a public offering price of $1.75 per share (the “Offering Price”).”

HYUNDAI ABS FUNDING LLC entered into Underwriting Agreement with Hyundai Capital America and BofA Securities, Inc., on its own behalf and as representative of the several underwriters valued at $1,647,010,000 (effective 2024-03-11).

“On March 11, 2024, Hyundai ABS Funding, LLC (“HABS”), Hyundai Capital America (“HCA”) and BofA Securities, Inc., on its own behalf and as representative of the several underwriters (the “Underwriters”) entered into an Underwriting Agreement, pursuant to which notes in the following classes: Class A-1, Class A-2-A, Class A-2-B, Class A-3, Class A-4, Class B and Class C Asset Backed Notes (collectively, the “Notes”) with an aggregate principal balance of $1,647,010,000 were sold to the Underwriters.”

APPLIED OPTOELECTRONICS, INC. entered into Equity Distribution Agreement with Raymond James & Associates, Inc. valued at up to $25 million (effective 2024-03-13).

“On March 13, 2024, Applied Optoelectronics, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Raymond James & Associates, Inc. (the “Sales Agent”) pursuant to which the Company may issue and sell shares of the Company’s common stock, par value $0.001 per share (the “Shares”) having an aggregate offering price of up to $25 million from time to time through the Sales Agent.”

IMPINJ INC entered into Settlement and Patent Cross-License Agreement with NXP Semiconductors N.V. and its subsidiary NXP USA, Inc. valued at $45.0 million one-time payment plus annual license fee payments starting at $15.0 million increasing (effective 2024-03-13).

“On March 13, 2024, Impinj, Inc. (“Impinj”) and NXP Semiconductors N.V. and its subsidiary NXP USA, Inc. (collectively, “NXP”) entered into a Settlement and Patent Cross-License Agreement dated March 13, 2024 (the “Agreement”), which resolves all outstanding litigation and other proceedings between them.”

RED RIVER BANCSHARES INC entered into Stock Repurchase Agreement with Angela Katherine Simpson Irrevocable Trust UA 25-NOV-03 and John Charles Simpson Jr. Irrevocable Trust UA 25-NOV-03 valued at 200,000 shares of common stock for $10,000,000 (approximately $50.00 per share) (effective 2024-03-13).

“On March 13, 2024, Red River Bancshares, Inc. (the “Company”) entered into a stock repurchase agreement (the “Stock Repurchase Agreement”) with the Angela Katherine Simpson Irrevocable Trust UA 25-NOV-03 and the John Charles Simpson Jr. Irrevocable Trust UA 25-NOV-03 (the “Stockholders”) for the purchase by the Company of 200,000 shares of the Company’s common stock, no par value per share (the “Common Stock”) from the Stockholders in a privately-negotiated transaction for a total purchase price of approximately $10.0 million.”

Hyperscale Data, Inc. entered into Note Purchase Agreement with two institutional investors valued at $2,000,000 principal face amount convertible promissory notes, purchase price $1,800,000, 6% interes (effective 2024-03-11).

“On March 11, 2024 (the “ Effective Date ”), Ault Alliance, Inc. (the “ Company ”) entered into a note purchase agreement (the “ Purchase Agreement ”) with two institutional investors (the “ Investors ”) pursuant to which the Investors agreed, severally and not jointly, to acquire, and the Company agreed to issue and sell in a registered direct offering to the Investors (the “ Offering ”), an aggregate of $2,000,000 principal face amount convertible promissory notes (the “ Notes ”), subject to customary closing conditions.”

SCHOLASTIC CORP entered into Securities Purchase Agreement with Niagara Investments, Ltd., ZMC Niagara Investment (Canada), Ltd., ZMC Niagara Investment (Cayman), L.P., Fansea Investments Ltd., UXL Investment Management Corporation, Commisso Trust, Vince Commisso, 2424886 Ontario Limited, Moon Shadow Inc., Jarosz Trust, Steven Jarosz, Tzia Limited, Natalie Osbor valued at CAD 250 million (approximately $186 million at current exchange rate) (effective 2024-03-11).

“On March 11, 2024, Scholastic Corporation (the “ Company ”) through 1000815816 Ontario Inc., a corporation organized and existing under the corporate laws of the Province of Ontario, Canada (the “ Purchaser ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) to acquire, indirectly, all of the economic interests in the form of non-voting shares and 25% of the voting shares in 9 Story Media Group Inc.”

EDUCATIONAL DEVELOPMENT CORP entered into Letter of Intent with Blue Ledge Group valued at $37,750,000 (effective 2024-03-06).

“Effective March 6, 2024, Educational Development Corporation (“EDC”, the “Company” or “Seller”) entered into a Letter of Intent with Blue Ledge Group (“Buyer”) to execute a Purchase and Sale Agreement for the Company’s headquarters and distribution warehouse”

Cadrenal Therapeutics, Inc. entered into At the Market Offering Agreement with H.C. Wainwright & Co., LLC valued at $5,143,730 (effective 2024-03-11).

“On March 11, 2024, Cadrenal Therapeutics, Inc., a Delaware corporation, (the “Company”), entered into an At the Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent to sell shares of the Company’s common stock”

Real Good Food Company, Inc. amended Amendment with PMC Financial Services Group, LLC valued at $45.0 million (effective 2024-03-07).

“On March 7, 2024, Real Good Foods, LLC, a wholly owned subsidiary of The Real Good Food Company, Inc. (the “Company”), entered into an amendment (the “Amendment”) to its amended and restated Loan and Security Agreement with PMC Financial Services Group, LLC (“PMC”), dated June 30, 2016 (the “Existing Credit Facility”).”

Zeo Energy Corp. entered into Non-Redemption Agreement with The K2 Principal Fund L.P. (effective 2024-03-11).

“On March 11, 2024, ESGEN Acquisition Corporation, a Cayman Islands exempted company incorporated with limited liability (“ESGEN”), entered into a non-redemption agreement (the “Non-Redemption Agreement”) with The K2 Principal Fund L.P. (“K2”)”

Lucy Scientific Discovery, Inc. terminated Amalgamation Agreement with Bluesky Biologicals Inc. (effective 2024-03-05).

“nd Bluesky Biologicals Inc., a corporation existing under the laws of the Province of British Columbia (“ Bluesky ” or “ Acquiree ”), entered into that certain Amalgamation Agreement (the “ Agreement ”), pursuant to”

Sovos Brands, Inc. terminated Credit Agreement with the financial institutions party thereto and Credit Suisse AG, Cayman Islands Branch, as Administrative Agent (effective 2024-03-12).

“Item 1.02. Termination of a Material Definitive Agreement. In connection with the consummation of the Merger (defined below), on March 12, 2024, the Company repaid in full all outstanding amounts under the First Lien Credit Agreement, dated as of June 8, 2021, as amended by that certain Amendment No. 1, dated June 28, 2023, by and among Sovos Brands Intermediate, Inc., Sovos Brands Holdings, Inc., the financial institutions party thereto and Credit Suisse AG, Cayman Islands Branch, as Administrative Agent, and all financing-related documents (the “ Credit Agreement ”), and terminated the Credit Agreement and all commitments by the lenders to extend further credit thereunder.”

Sovos Brands, Inc. entered into Merger Agreement with Campbell Soup Company and Premium Products Merger Sub, Inc. (effective 2024-03-12).

“er Agreement ”), by and among Sovos Brands, Inc. (the “ Company ”), Campbell Soup Company (“ Campbell ”) and Premium Products Merger Sub, Inc., a wholly-owned subsidiary of Campbell (“ Merger Sub ”).”

ExcelFin Acquisition Corp. amended First Amendment to the Business Combination Agreement with Betters Medical Investment Holdings Limited valued at Amendment to business combination agreement, including changes to earnout shares, SPAC closing cash (effective 2024-03-11).

“(“ ExcelFin ”), Betters Medical Investment Holdings Limited (“ Betters ”), Baird Medical Investment Holdings Limited (“ PubCo ”), Betters Medical Merger Sub, Inc.”

Focus Impact BH3 Acquisition Co entered into Business Combination Agreement with XCF Global Capital, Inc. (effective 2024-03-11).

“On March 11, 2024, BHAC entered into a Business Combination Agreement (the “Business Combination Agreement”) with Focus Impact BH3 Newco, Inc.”

Bannix Acquisition Corp. amended Trust Amendment with Continental Stock Transfer & Trust Company (effective 2024-03-08).

“(the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”) entered into an amendment, dated March 8, 2024 (the “Trust Amendment”) to the Investment Management Trust Agreement, dated as of September 14, 2021,”

Bannix Acquisition Corp. terminated Business Combination Agreement with EVIE Autonomous Group Ltd. and the shareholder of the EVIE Group (effective 2024-03-11).

“On March 11, 2024, Bannix sent EVIE Group and the EVIE Group Shareholder a notice providing that the Business Combination Agreement has been terminated as a result of the failure of EVIE Group and the EVIE Group Shareholder to loan or procure a loan to Bannix as required pursuant to Section 5.21 of the Business Combination Agreement.”

Iris Acquisition Corp entered into Administrative Support Agreement with Arrow Capital Management LLC valued at $10,000 per month (effective 2024-03-11).

“On March 11, 2024, the Company entered into an administrative support agreement (the "Agreement") with Arrow Capital Management LLC ("Arrow").”

Iris Acquisition Corp amended Amended Note with Liminatus Pharma LLC valued at up to $2,500,000 (effective 2024-02-28).

“On February 28, 2024, the Company and the Payee amended and restated the Note (the "Amended Note"). The Amended Note increased the aggregate principal amount to up to $2,500,000, and added advances that occurred under the Note.”

Iris Acquisition Corp entered into Promissory Note with Liminatus Pharma LLC valued at up to $1,500,000 (effective 2023-10-04).

“On October 4, 2023, Iris Acquisition Corp, a Delaware corporation (the "Company") issued an unsecured promissory note in the aggregate principal amount up to $1,500,000 (the "Note") to Liminatus Pharma LLC (the "Payee").”

Li-Cycle Holdings Corp. entered into Note Purchase Agreement with Glencore Ltd. and Glencore Canada Corporation valued at $75,000,000 (effective 2024-03-11).

“On March 11, 2024, Li-Cycle Holdings Corp. (the “ Company ”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”) with Glencore Ltd. (“ Glencore Intermediate ”), and Glencore Canada Corporation (“ Glencore ”, and together with Glencore Intermediate, the “ Glencore Parties ”), pursuant to which the Company agreed to issue and sell to Glencore a senior secured convertible note (the “ Senior Secured Convertible Note ”) in an aggregate principal amount of $75,000,000”

Mondee Holdings, Inc. amended Amendment No. 13 with TCW Asset Management Company, Wingspire Capital LLC, and the lenders from time to time (effective 2024-03-11).

“On March 11, 2024, Mondee Holdings, Inc., a Delaware corporation (the “ Company ”), and certain of its subsidiaries, on the one hand, and TCW Asset Management Company, a Delaware limited liability company (the “ Administrative Agent ”), Wingspire Capital LLC, a Delaware limited liability company (“ Wingspire ”), and the lenders from time to time (the “ Lenders ”) party to the Financing Agreement (as defined herein), on the other hand, entered into that certain Amendment No. 13 (the “ Amendment ”) to that certain financing agreement, dated as of December 23, 2019”

Airspan Networks Holdings Inc. amended Limited Waiver and Consent, Seventh Amendment to Senior Secured Convertible Note Purchase and Guarantee Agreement and Reaffirmation of Note Documents (the NPA Amendment) with the purchasers party thereto and the administrative and collateral agent (effective 2024-03-07).

“In connection with the Sixth A&R Credit Agreement, the Company modified the terms of its Senior Secured Convertible Note Purchase and Guarantee Agreement, dated July 30, 2021 (as further amended, amended and restated, restated, supplemented or otherwise modified from time to time prior to the Effective Date, the “Note Purchase Agreement”) pursuant to the Limited Waiver and Consent, Seventh Amendment to Senior Secured Convertible Note Purchase and Guarantee Agreement and Reaffirmation of Note Documents, dated the Effective Date (the “NPA Amendment”), among the Company, ANI, certain of its subsidiaries as guarantors, the purchasers party thereto and the administrative and collateral agent.”

Airspan Networks Holdings Inc. amended Limited Waiver and Consent, Sixth Amendment and Restatement of Credit Agreement and Reaffirmation of Loan Documents (the Sixth Amendment and Restatement Agreement) with DBFIP ANI LLC, as administrative agent and collateral agent valued at $18 million (effective 2024-03-07).

“On March 7, 2024 (the “Effective Date”), Airspan Networks Holdings Inc., a Delaware corporation (the “Company”), entered into the Limited Waiver and Consent, Sixth Amendment and Restatement of Credit Agreement and Reaffirmation of Loan Documents (the “Sixth Amendment and Restatement Agreement”) among the Company, as Holdings (in such capacity, “Holdings”), Airspan Networks Inc., a Delaware corporation (“ANI”), as the Borrower (in such capacity, the “Borrower”), certain subsidiaries of the Company, as guarantors, the lenders party thereto (collectively, the “Lenders”) and DBFIP ANI LLC, as administrative agent and collateral agent (together with its successors and assigns in such capacities, the “Agent”).”

Astra Space, Inc. entered into Warrant Exchange Agreement with each holder of Warrants.

“a warrant exchange agreement, by and among Parent, Merger Sub, and each holder of Warrants (the “ Warrant Exchange Agreement ”)”

Astra Space, Inc. entered into Noteholder Conversion Agreement with each holder of Convertible Notes.

“a noteholder conversion agreement, by and among Parent, Merger Sub, and each holder of Convertible Notes (the “ Noteholder Conversion Agreement ”)”

Astra Space, Inc. entered into Agreement and Plan of Merger with Apogee Parent Inc., Apogee Merger Sub Inc. (effective 2024-03-07).

“the Company, Apogee Parent Inc., a Delaware corporation (“ Parent ”), and Apogee Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”)”

Rackspace Technology, Inc. entered into First Lien Credit Agreement with Citibank, N.A., administrative agent and collateral agent (effective 2024-03-12).

“the New Borrower entered into a First Lien Credit Agreement, dated March 12, 2024 (the “ New Credit Agreement ”), among Rackspace Finance Holdings, LLC (“ New Holdings ”), the New Borrower, the lenders and issuing banks party thereto and Citibank, N.A., as administrative agent and collateral agent”

Aprea Therapeutics, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of approximately $16.0 million (effective 2024-03-11).

“On March 11, 2024, Aprea Therapeutics, Inc. (the "Company") entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain investors (the "Purchasers"), pursuant to which the Company agreed to issue and sell to the Purchasers, and the Purchasers agreed to purchase from the Company (i) 1,687,712 shares (the "Private Placement Shares") of the Company’s Common Stock, par value $0.001 per share ("Common Stock") at a purchase price of $7.29 per share, (ii) pre-funded Common Stock purchase warrants (the "Pre-Funded Warrants") to purchase an aggregate of up to 507,076 shares of Common Stock at an exercise price of $0.001 per share, (iii) Tranche A Common Stock purchase warrants to purchase up to 1,097,394 shares of Common Stock at an exercise price of $7.29 per share (the "Tranche A Warrants"), and (iv) Tranche B Common Stock purchase warrants to purchase up to 1,097,394 shares of Common Stock at an exercise price of $9.1125 per share (the "Tranche B Warrants"”

Powerfleet, Inc. entered into Facilities Agreement with FirstRand Bank Limited (acting through its Rand Merchant Bank division) valued at $85 million (effective 2024-03-07).

“On March 7, 2024, PowerFleet, Inc. (the “Company”), together with I.D. Systems, Inc. (“IDSY”) and Movingdots GmbH (“Movingdots” and, collectively with the Company and IDSY, the “Obligors”), each a wholly owned subsidiary of the Company, entered into a Facilities Agreement (the “Facilities Agreement”) with FirstRand Bank Limited (acting through its Rand Merchant Bank division) (“RMB”), pursuant to which RMB has agreed to provide the Company with two term loan facilities in an aggregate principal amount of $85 million, comprised of two facilities in the aggregate principal amount of $42.5 million and $42.5 million, respectively (the “Term A Facility” and “Term B Facility,” respectively, and, collectively, the “Term Facilities”).”

PLIANT THERAPEUTICS, INC. amended Amended and Restated Loan and Security Agreement with Oxford Finance LLC and the lenders valued at $150.0 million (effective 2024-03-11).

“On March 11, 2024 (the “Effective Date”), Pliant Therapeutics, Inc. (the “Company”) entered into an Amended and Restated Loan and Security Agreement (“Agreement”) by and among the Company, the lenders from time to time party thereto (each a “Lender” and collectively, the “Lenders”) and Oxford Finance LLC, in its capacity as collateral agent (in such capacity, the “Agent”), which amends and restates, in its entirety, the Loan and Security Agreement, dated as of May 4, 2022”

International Money Express, Inc. entered into Share Repurchase Agreement valued at approximately $3.3 million (effective 2024-03-11).

“On March 11, 2024, International Money Express, Inc. (the “ Company ”) entered into a share repurchase agreement (the “ Share Repurchase Agreement ”) with Robert W. Lisy (the “ Stockholder ”), the Company’s Chief Executive Officer, President and Chairman of the Board of Directors (the “Board”), for the purchase of 175,000 shares of the Company’s common stock”

Alcoa Corp entered into Scheme Implementation Deed with Alumina Limited (effective 2024-03-11).

“On March 11, 2024 (Eastern Daylight Time) / March 12, 2024 (Australian Eastern Daylight Time), Alcoa Corporation, a Delaware corporation (“ Alcoa ”), AAC Investments Australia 2 Pty Ltd, an Australian proprietary company limited by shares and an indirect wholly owned subsidiary of Alcoa (“ Alcoa Bidder ”), and Alumina Limited, an Australian public company limited by shares and listed on the Australian Securities Exchange (“ Alumina ”), entered into a Scheme Implementation Deed (the “ Deed ”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, Alcoa Bidder will acquire all Alumina ordinary shares on issue and outstanding”

Delek Logistics Partners, LP entered into Underwriting Agreement with Truist Securities, Inc., BofA Securities, Inc., Raymond James & Associates, Inc. valued at Sale of 3,116,884 common units at $38.50 per unit, plus option for up to 467,532 additional units (effective 2024-03-07).

“On March 7, 2024, Delek Logistics Partners, LP (the “Partnership”) entered into an underwriting agreement (the “Underwriting Agreement) by and among the Partnership, Delek Logistics GP, LLC, a Delaware limited liability company and the general partner of the Partnership, and Truist Securities, Inc., BofA Securities, Inc. and Raymond James & Associates, Inc., as joint book-running managers and representatives of the several underwriters named on Schedule A thereto (collectively, the “Underwriters”), pursuant to which the Underwriters agreed to sell to the public 3,116,884 common units representing limited partner interests in the Partnership (“Firm Units”) at a price of $38.50 per Unit (the “Offering”).”

Norwegian Cruise Line Holdings Ltd. terminated Secured Notes Indenture with the holders of the Secured Notes valued at NCLC repurchased all outstanding 9.75% Senior Secured Notes due 2028 in aggregate principal amount o (effective 2024-03-11).

“On March 11, 2024, in connection with the settlement of the Repurchase, the Trustee cancelled the aggregate principal amount outstanding under the Secured Notes and confirmed that NCLC had satisfied and discharged its obligations under the Secured Notes Indenture.”

Norwegian Cruise Line Holdings Ltd. amended Third Amended and Restated Commitment Letter with funds managed by affiliates of Apollo Global Management (the Apollo Funds) valued at up to $650.0 million of senior unsecured notes due five years after the issue date (effective 2024-03-11).

“On February 23, 2024, NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd., entered into a third amended and restated commitment letter (the “Amended Commitment Letter”) with funds managed by affiliates of Apollo Global Management (the “Apollo Funds”), which became effective on March 11, 2024 and which amends, restates and supersedes the second amended and restated commitment letter, dated February 22, 2023, among NCLC and the Apollo Funds.”

Streamex Corp. entered into Promissory Note with an investor valued at $500,000 (effective 2024-03-07).

“On March 7, 2024, BioSig Technologies Inc. (the “Company”) issued a Promissory Note (the “Note”) to an investor for $500,000.”

Avinger Inc amended Fourth Amendment to Lease with HCP LS Redwood City, LLC valued at $1,272,432 in annual base rent (effective 2024-03-06).

“On March 6, 2024, we entered into the Fourth Amendment to Lease with the Landlord (the “Fourth Amendment”), which amended the Lease to extend the lease term with respect to the 400 Building for a period of one year.”

NS Wind Down Co., Inc. entered into Asset Purchase Agreement with an affiliate of Patient Square Capital valued at $220,000,000 (effective 2024-03-10).

“On March 10, 2024, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with an affiliate of Patient Square Capital (“Patient Square”) to sell substantially all of the assets of the Company and its subsidiaries (the “Business”) for a cash purchase price of $220,000,000 (the “Purchase Price”)”

Calumet Specialty Products Partners, L.P. amended Amendment with Wilmington Trust, National Association (effective 2024-03-08).

“In connection with the issuance of the Notes, on March 8, 2024, the Issuers and the guarantors under the Indenture (other than Calumet Montana Refining, LLC) entered into an amendment (the “Amendment”) to (i) the Amended and Restated Collateral Trust Agreement (the “Collateral Trust Agreement”) with Wilmington Trust, National Association, as collateral trustee (in such capacity, the “Collateral Trustee”), the Trustee and the representatives of certain other holders of Parity Lien Obligations (as defined in the Collateral Trust Agreement) and (ii) the Second Amended and Restated Security and Pledge Agreement with the Collateral Trustee.”

Calumet Specialty Products Partners, L.P. entered into Indenture with Wilmington Trust, National Association valued at $200.0 million aggregate principal amount (effective 2024-03-07).

“On March 7, 2024, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”) issued $200.0 million aggregate principal amount of a new series of the Issuers’ 9.25% Senior Secured First Lien Notes due 2029 (the “Notes”) in a private placement transaction in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).”

Lazard Group LLC amended Tenth Supplemental Indenture with The Bank of New York Mellon valued at $400,000,000 (effective 2024-03-12).

“The Notes were issued pursuant to a tenth supplemental indenture, dated March 12, 2024, (the “Tenth Supplemental Indenture”), between the Company and The Bank of New York Mellon, as trustee, to an indenture, dated May 10, 2005 (the “Indenture”), between the Company and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee.”

Lazard Group LLC entered into Underwriting Agreement with Citigroup Global Markets Inc., as representative of the several underwriters valued at $400,000,000 (effective 2024-03-06).

“On March 6, 2024, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., as representative of the several underwriters listed on Schedule I thereto (collectively, the “Underwriters”), pursuant to which the Company agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, the Notes.”